This study investigates the effectiveness and safety of a subcutaneous treatment for people aged 12 and older with moderate-to-severe atopic dermatitis. Participants in this study have not responded well to previous treatments, such as biologic therapies or oral JAK inhibitors.The study focuses on understanding how well the treatment works and …
This study investigates the effect of an investigational medication, an Anti-OX40L Monoclonal Antibody, in adults with moderate to severe atopic dermatitis. The study will compare the investigational medication to other treatment arms to assess its effectiveness.Participants will be randomly assigned to one of five study arms in a double-blind manner, …
This study investigates atopic dermatitis (AD) in adolescents and adults who are starting or changing systemic treatments. The purpose of this study is to understand the needs of patients with AD and to evaluate the safety and outcomes of these treatments in real-life settings.The study focuses on understanding the patient …
This study investigates the effects of atopic dermatitis (AD) on pregnancy outcomes. This observational study will compare the incidence of adverse pregnancy outcomes, such as miscarriage or stillbirth, and the prevalence of adverse infant outcomes, like major congenital malformations or being small for gestational age, in women with AD who …
